FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and deals with a method of determining in an individual's sample of a protein of neutrophilic origin, gelatinase-associated lipocalin (NGAL), for determination of acute kidney injury in the individual, where the predominating amount of monomer and/or heterodimer forms of NGAL protein, in comparison with the dimer form of NGAL protein, shows that NGAL protein originates from the individual's kidneys and that the individual has acute kidney injury, whereas equal or predominating amount of the dimer form of NGAL protein, in comparison with the monomer or heterodimer form of NGAL protein shows that NGAL protein originates from the individual's neutrophils and that the said individual does not have acute kidney injury; a set for determination of relative amounts of monomer, dimer or heterodimer forms of NGAL; application of the device in the said method.
EFFECT: group of inventions ensures more accurate diagnosis and therefore contributes to better directed treatment.
17 cl, 2 ex, 10 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EARLY DIAGNOSTICS OF ACUTE RENAL INJURY IN ONCUUROLOGICAL PATIENTS AFTER RADICAL CYSTECTOMY | 2021 |
|
RU2760501C1 |
SOLID PHASE ENZYME-IMMUNOASSAY (ELIZA) FOR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) | 2007 |
|
RU2517301C2 |
METHOD FOR DETERMINATION OF MEMBERS OF FAMILY OF S100 CALCIUM-BINDING PROTEINS BY MEANS OF IMMUNOTURBIDIMETRY | 2018 |
|
RU2780565C2 |
METHOD OF PREDICTING THE STATE OF PATIENTS WITH DISEASES ACCOMPANIED WITH ACUTE KIDNEY INJURY BY DETERMINING THE PARTIAL PRESSURE OF CARBON DIOXIDE IN URINE | 2022 |
|
RU2796739C1 |
CANCER DETECTION BY HIGH BCL-2 LEVELS | 2007 |
|
RU2436098C2 |
IL-1 ALPHA AND BETA BISPECIFIC IMMUNOGLOBULINS WITH DOUBLE VARIABLE DOMAINS AND THEIR APPLICATION | 2011 |
|
RU2627171C2 |
METHODS AND COMPOSITIONS FOR TREATING LUPUS | 2010 |
|
RU2607022C2 |
HIGH-SENSITIVITY IMMUNOASSAYS AND KITS FOR DETECTING PEPTIDES AND PROTEINS OF INTEREST | 2007 |
|
RU2461837C2 |
COMPOSITION AND METHOD FOR DETECTING MALIGNANT NEOPLASTIC DISEASE | 2015 |
|
RU2678135C1 |
METHOD OF DETECTING DEGENERATIVE MUSCULAR DISEASES AND METHOD OF DETERMINING THERAPEUTIC EFFICIENCY IN CASE OF DISEASES | 2010 |
|
RU2524641C2 |
Authors
Dates
2014-06-20—Published
2009-11-23—Filed